Nykode Therapeutics AS (OSL: NYKD)
6.44
-0.16 (-2.42%)
Aug 30, 2024, 4:25 PM CET
Nykode Therapeutics AS Revenue
Nykode Therapeutics AS had revenue of $584.00K USD in the quarter ending June 30, 2024, a decrease of -88.55%. This brings the company's revenue in the last twelve months to $6.52M, down -49.83% year-over-year. In the year 2023, Nykode Therapeutics AS had annual revenue of $13.32M with 47.56% growth.
Revenue (ttm)
$6.52M
Revenue Growth
-49.83%
P/S Ratio
29.70
Revenue / Employee
$37.66K
Employees
173
Market Cap
2.10B NOK
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 533.17M |
Nordhealth AS | 471.77M |
Photocure ASA | 513.58M |
Carasent ASA | 254.01M |
ArcticZymes Technologies ASA | 117.80M |
Hofseth BioCare ASA | 230.08M |
Gentian Diagnostics ASA | 151.51M |
Navamedic ASA | 543.49M |